| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Norgestrel | FAERS: 35 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 2 | NuvaRing | FAERS: 6 | US FAERS | |
| 3 | Medroxyprogesterone Acetate | FAERS: 5 | US FAERS | |
| 4 | Copper | FAERS: 3 | US FAERS | |
| 5 | Estrogens, Conjugated (USP) | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Ceftriaxone | FAERS: 1 | US FAERS | |
| 7 | Dinoprostone | FAERS: 1 | US FAERS | |
| 8 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 9 | Gefitinib | FAERS: 1 | US FAERS | |
| 10 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 11 | Meropenem | FAERS: 1 | US FAERS | |
| 12 | Metronidazole | FAERS: 1 | US FAERS | |
| 13 | Valproic Acid | FAERS: 1 | US FAERS | |
| 14 | rofecoxib | FAERS: 1 | US FAERS | |
| 15 | teriflunomide | FAERS: 1 | US FAERS | |
| 16 | Bortezomib | OFFSIDES | ||
| 17 | Clomipramine | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.